Cong, Lin <br/><br/>
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy.  [electronic resource] 

 -  Archiv der Pharmazie  Sep 2014 
 - 609-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-4184 
<br/><br/><label>Standard No.: </label>10.1002/ardp.201400116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Heterocyclic Compounds, 3-Ring--chemistry<br/>Humans<br/>Imidazoles--chemistry<br/>Molecular Docking Simulation<br/>Molecular Dynamics Simulation<br/>Molecular Structure<br/>Molecular Targeted Therapy<br/>Morpholines--chemistry<br/>Protein Binding<br/>Protein Kinase Inhibitors--chemistry<br/>Pyrazoles--chemistry<br/>Quinolines--chemistry<br/>Quinoxalines--chemistry<br/>Receptors, Transforming Growth Factor beta--antagonists & inhibitors<br/>Scleroderma, Systemic--drug therapy